RecruitingNCT03559569

Impact of Endothelial and Leukocyte Senescence in Circulatory Shock States


Sponsor

University Hospital, Strasbourg, France

Enrollment

520 participants

Start Date

Jan 7, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

Circulatory shocks (CS) are life-threatening, acute organ dysfunction. Advances in critical care medicine have decreased early hospital mortality, increasing the number of surviving patients. Regrettably, these survivors are at increased risk of new infections but also of cardiovascular disease. The investigators hypothesize that CS with multi-organ dysfunction is associated with premature senescence of endothelial cells and immune cells and promotes endothelial thrombogenicity and immunosenescence leading to cardiovascular disease and secondary infections. The aim of this work is therefore to evaluate the contribution of endothelial and leucocytes senescence to the occurrence of secondary events (infectious and cardiovascular) in patients with a CS. It will provide a better understanding of the pathogenesis of cardiovascular and immune diseases following a CS, likely to guide new management strategies to prevent their occurrence.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Circulatory shock
  • patient with health care insurance

Exclusion Criteria4

  • Patients' refusal to participate in clinical research
  • Pregnant woman
  • Breastfeeding woman
  • A patient with a protective order

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALBiological samples will be done to evaluate the endothelial and leukocyte senescence.

Noninvasive, reproducible, and sensitive methods to measure cardiac function, endothelial function, and arterial stiffness will be assess.


Locations(1)

Hôpitaux Universitaires de Strasbourg - Service de Réanimation médicale du NHC

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03559569


Related Trials